ChemAbout

ChemAbout is a B2B platform where chemical buyers and suppliers discover each other.

Post a purchase requestList your products (for suppliers)
© 2026 ChemAbout
Compound Index|Demand Board|Insights|Exhibitions|Compliance|Help Center|Privacy Policy|Terms of Service|[email protected]
Home/Compounds/Pharmaceutical Intermediate/MC-Val-Ala-PAB-PNP
C32H37N5O10
651.7 g/mol
Pharmaceutical Intermediate

MC-Val-Ala-PAB-PNP

CAS1639939-40-4
Category
Pharmaceutical Intermediate
Compound Class
Peptide
Primary Use
Pharmaceutical Intermediate

MC-Val-Ala-PAB-PNP is a chemical compound used as a linker reagent in the manufacturing of antibody-drug conjugates (ADCs). It contains a maleimide group for cysteine conjugation, a valine-alanine dipeptide cleavable by cathepsin B, and a p-nitrophenyl carbonate group for drug attachment.

Antibody-drug conjugate linker reagentLaboratory reagent for bioconjugation research

Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.

Sourcing MC-Val-Ala-PAB-PNP?

Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.

Post a Purchase Request→Supplier? List your product for this CAS→

Related Compounds

SimilarStructure SimilarSimilarity 0.78

MC-Val-Cit-PAB-PNP

CAS159857-81-5

research compound

ReferenceSame Category

2,3,3-Trimethylindolenine

CAS1640-39-7

pharmaceutical intermediate

ReferenceSame Category

Ethyl 4-acetoxy-1-benzyl-2-methyl-1H-benzo[d]imidazole-6-carboxylate

CAS1640981-11-8

pharmaceutical intermediate

ReferenceSame Category

Decane-d22

CAS16416-29-8

pharmaceutical intermediate

ReferenceSame Category

4-(Chloromethyl)benzoic acid

CAS1642-81-5

pharmaceutical intermediate

Related Reading

Therapeutic Peptides in 2026: This Year's Breakthroughs

2026 has been a concentrated year for peptide therapeutics. Efficacy reached a new high in late-stage trials, the obesity field moved beyond the incretins to amylin, the oral route reached weight management, and peptide-guided radioligand therapy kept advancing — each point tied to a specific 2025–2026 result.

Read more
Identifiers
IUPAC Name

[4-[[(2S)-2-[[(2S)-2-[6-(2,5-dioxopyrrol-1-yl)hexanoylamino]-3-methylbutanoyl]amino]propanoyl]amino]phenyl]methyl (4-nitrophenyl) carbonate

InChIKey

QXMLUPPUFBNKRY-LGGPFLRQSA-N

SMILES

C[C@@H](C(=O)NC1=CC=C(C=C1)COC(=O)OC2=CC=C(C=C2)[N+](=O)[O-])NC(=O)[C@H](C(C)C)NC(=O)CCCCCN3C(=O)C=CC3=O

Synonyms (6)
  • MC-Val-Ala-PAB-PNP
  • Mal-Val-Ala-PAB-PNP

Sourcing MC-Val-Ala-PAB-PNP?

Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.

Post a Purchase Request→Supplier? List your product for this CAS→